Author details

Full Name

Lloyd Mayer

Affiliation

ORCID

Career Start Year

1976

Papers

284

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
33671498	Wnt/Î²-Catenin Signaling Regulates CXCR4 Expression and [Ga] Pentixafor Internalization in Neuroendocrine Tumor Cells.	Diagnostics	2021
31416849	Editor's Note: Toll-Like Receptors on Tumor Cells Facilitate Evasion of Immune Surveillance.	Cancer Research	2019
31416850	Editor's Note: Promotes Tumor Growth via Tumor Cell Toll-Like Receptor 2 Signaling.	Cancer Research	2019
28892060	A functional genomics predictive network model identifies regulators of inflammatory bowel disease.	Nat Genet	2017
28806280	Integrated Analysis of Biopsies from Inflammatory Bowel Disease Patients Identifies SAA1 as a Link Between Mucosal Microbes with TH17 and TH22 Cells.	Inflamm Bowel Dis	2017
27745954	Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.	Vaccine	2016
26656297	Chromoendoscopy Is More Effective Than Standard Colonoscopy in Detecting Dysplasia During Long-term Surveillance of Patients With Colitis.	Clin Gastroenterol Hepatol	2016
25826676	Expression of Blimp-1 in dendritic cells modulates the innate inflammatory response in dextran sodium sulfate-induced colitis.	Mol Med	2015
25540149	High-dose infliximab therapy in Crohn's disease: clinical experience, safety, and efficacy.	J Crohns Colitis	2015
24576111	Potential non-T cells source of interleukin-4 in food allergy.	Pediatric Allergy and Immunology	2014
23945543	Oligoclonal expansions of mucosal T cells in Crohn's disease predominate in NKG2D-expressing CD4 T cells.	Mucosal Immunology	2014
24252977	Anti-inflammatory effects of the Chinese herbal formula FAHF-2 in experimental and human IBD.	Inflammatory Bowel Diseases	2014
24104458	Characterizing CEACAM5 interaction with CD8Î± and CD1d in intestinal homeostasis.	Mucosal Immunology	2014
23461895	Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study.	Gut	2014
23695510	IL-22-producing CD4+ cells are depleted in actively inflamed colitis tissue.	Mucosal Immunology	2014
24636473	The natural history of egg allergy in an observational cohort.	J Allergy Clin Immunol	2014
24583479	Metabolic alterations to the mucosal microbiota in inflammatory bowel disease.	Inflammatory Bowel Diseases	2014
23501398	Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency.	Clinical Gastroenterology and Hepatology	2013
22763407	IL-13-mediated immunological control of enterochromaffin cell hyperplasia and serotonin production in the gut.	Mucosal Immunology	2013
24072822	Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals.	Science	2013
23960190	Lung dendritic cells induce migration of protective T cells to the gastrointestinal tract.	Journal of Experimental Medicine	2013
23273958	The natural history of milk allergy in an observational cohort.	J Allergy Clin Immunol	2013
23232296	Transforming growth factor Î² signaling controls activities of human intestinal CD8(+)T suppressor cells.	Gastroenterology	2013
23265698	Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial.	J Allergy Clin Immunol	2013
23265693	Can we produce true tolerance in patients with food allergy?	Journal of Allergy and Clinical Immunology	2013
23429460	Safety and tolerability of human placenta-derived cells (PDA001) in treatment-resistant crohn's disease: a phase 1 study.	Inflamm Bowel Dis	2013
23223361	Accumulation of peripheral autoreactive B cells in the absence of functional human regulatory T cells.	Blood	2013
23256766	Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease: an update.	Expert Review of Clinical Immunology	2013
23615072	Extended haplotype association study in Crohn's disease identifies a novel, Ashkenazi Jewish-specific missense mutation in the NF-ÎºB pathway gene, HEATR3.	Genes Immun	2013
21438101	Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines.	Inflammatory Bowel Diseases	2012
22643351	A role for the epidermal growth factor receptor signaling in development of intestinal serrated polyps in mice and humans.	Gastroenterology	2012
22466933	Working out mechanisms of controlled/physiologic inflammation in the GI tract.	Immunologic Research	2012
22626501	Dead on arrival: understanding the failure of CTLA4-immunoglobulin therapy in inflammatory bowel disease.	Gastroenterology	2012
22287300	Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA Partners): methodology and initial results.	Inflammatory Bowel Diseases	2012
22528123	Introduction to the special issue on Immunology at Mount Sinai.	Immunologic Research	2012
22412388	A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci.	PLoS Genet	2012
22447352	Mucosal immunology of tolerance and allergy in the gastrointestinal tract.	Immunologic Research	2012
22101768	Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut.	Nat Med	2011
21489888	Diagnosis and treatment of primary immunodeficiency disease in patients with gastrointestinal symptoms.	Clinical Immunology	2011
21147109	Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases.	Gastroenterology	2011
21056041	Notch-1 signaling regulates intestinal epithelial barrier function, through interaction with CD4+ T cells, in mice and humans.	Gastroenterology	2011
21531240	Shared experiences and best practices in the management of rheumatoid arthritis and Crohn's disease.	American Journal of Medicine	2011
20956091	High levels of Crohn's disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous disease.	Clin Immunol	2011
20629103	Characterization of immunologic defects in patients with common variable immunodeficiency (CVID) with intestinal disease.	Inflamm Bowel Dis	2011
20535023	Mesalamine (5-aminosalicylic acid) therapy well tolerated in a patient with aspirin hypersensitivity and ulcerative colitis.	Journal of Clinical Gastroenterology	2011
21587231	Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation.	Nature Communications	2011
21762973	Allergic sensitization can be induced via multiple physiologic routes in an adjuvant-dependent manner.	Journal of Allergy and Clinical Immunology	2011
21674704	Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis.	Inflammatory Bowel Diseases	2011
21548950	Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control study.	BMC Medical Genetics	2011
20664576	Attenuation of TNF-driven murine ileitis by intestinal expression of the viral immunomodulator CrmD.	Mucosal Immunology	2010